抗微生物及其结合衍生物的应用现状
Marcel Lí Del Olmo1, Cecilia Andreu2
1Departament de Bioquímica i Biologia Molecular, Universitat de València (UVEG), Doctor Moliner 50, 46100 Burjassot, València, Spain.
Molecules (Basel, Switzerland)
|August 14, 2025
概括
抗生素耐药细菌的增加需要新的抗菌化合物. 本综述探讨了抗微生物 (AMP) 和新的策略,如纳米粒子结合,以提高它们对抗耐药病原体的有效性.
科学领域:
- 生物化学和分子生物学
- 药物发现和开发 药物发现和开发
- 微生物学 微生物学
背景情况:
- 抗生素耐药性是一个关键的全球健康挑战,推动了对新型抗菌剂的需求.
- 抗微生物 (AMP) 是一类具有广谱活性的有前途的天然化合物.
- 现有的AMP面临挑战,包括消化道的稳定性和有针对性的分娩.
研究的目的:
- 审查有关各种类型的AMP的当前知识.
- 阐明AMP的作用机制.
- 探索提高AMP绩效和克服局限性的策略.
主要方法:
- 关于抗微生物的科学出版物的文献综述.
- 对AMP机制的分析,包括膜破坏和细胞内点.
- 对AMP的结合策略和交付系统的检查.
主要成果:
- AMP表现出多种机制,准细菌细胞表面和重要的细胞内过程.
- 与纳米粒子,囊泡,水凝和碳纳米管等载体的结合提高了AMP的稳定性和有效性.
- 先进的交付系统对于保持AMP完整性和增强活动至关重要.
结论:
- 抗微生物代表了打击抗生素耐药性的重要前沿.
- 战略修改和交付系统是释放AMP的全部治疗潜力的关键.
- 对AMP结合物和载体的进一步研究对于开发下一代抗菌疗法至关重要.
相关概念视频
01:23Antimicrobial Proteins
5.2K
Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
5.2K
01:28Antimicrobial Effectiveness
157
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
157